Prospective Registry of Young-Adult Patients Diagnosed With Pancreatic Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-55
SponsorAzienda Ospedaliera Universitaria Integrata Verona
About this trial
The objective of the present registry is the creation of a prospective registry collecting clinico-pathological and genomic data, along with survival outcomes, of individuals diagnosed with PDAC at or before the age of 55 years old. This registry is intended with the aim of using collected data for future clinical trials, both prospective and retrospective.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≤55 years old at the time of diagnosis of pancreatic cancer
Age ≥ 18 years
Written informed consent obtained.
Disqualifiers
Any pancreatic neoplasm other than pancreatic cancer (e.g. cholangiocarcinoma, ampullary cancer,duodenal cancer, non-invasive mucinous cystic neoplasm, pancreatic intra-epithelial neoplasia 1 and 2, non-invasive intraductal papillary mucinous neoplasm, serous cystic neoplasm, pseudo papillary solid tumor, neuroendocrine tumor)
Absence of informed consent.
Age < 18 years or > 55 years old at the time of diagnosis of pancreatic cancer
Trial population
The target population is represented by individuals who have received a pathological diagnosis of pancreatic cancer before the age of 55 years old (namely, EO-PDAC patients). No subject will be financially compensated for their participation.
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Register
Other interventionProspective collection of epidemiological, clinical, and pathological data of patients diagnosed with early-onset pancreatic cancer (EO-PDAC) - namely, individuals who have received a diagnosis of pancreatic cancer before, or at, the age of 55 years old.
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Register of young PDAC patients
Prospective collection of epidemiological, clinical, and pathological data of patients diagnosed with early-onset pancreatic cancer (EO-PDAC) - namely, individuals who have received a diagnosis of pancreatic cancer before, or at, the age of 55 years old.
Time frame
30 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov